Morning Briefing
Summaries of health policy coverage from major news organizations
Judge Rejects Motion To Overturn Verdict Upholding Amgen's Cholesterol Drug Patents
Reuters: Sanofi, Regeneron Lose Bid To Overturn Amgen Win In Patent Case
A federal judge on Tuesday refused to throw out a court verdict upholding two Amgen Inc patents related to the company's cholesterol drug, a defeat for Sanofi SA and Regeneron Pharmaceuticals Inc, which make a rival drug. In an October 2014 lawsuit, Amgen had sought to stop Paris-based Sanofi and Tarrytown, New York-based Regeneron from selling Praluent, a drug intended to lower bad LDL cholesterol by blocking a protein known as PCSK9. (Pierson, 1/3)
The Associated Press: FDA Probes Dangers Of Exploding E-Cigarette Batteries
The U.S. Food and Drug Administration is probing the dangers of exploding batteries in e-cigarettes, following dozens of reports of devices that have combusted, overheated or caught fire and sometimes injured users. (1/3)
